News About: Pharm. Affairs
Original erectile dysfunction therapies’ “Endless downturns”
Original erectile dysfunction treatments is getting weaker and weaker in market power.
Leading products, Pfizer’s Viagra(sildenafil citrate) and Lilly’s Cialis(tadalafil) lost more than 20% of quarterly prescriptions...
Mercilon Tab, top OTC contraceptive, fell while Meliane Tab narrowly stepped forward
It was observed the OTC market for contraceptives will be shrunk in 2015 compared to 2014.
Particularly, Mercilon Tab which has kept the top position in the OTC contraceptive market made a -16% record in sales; the t...
Miscarried ‘cervical cancer vaccination,’ starting re-tender this week
While the Public Procurement Service’s tender for Gardasil and Cervarix, the subject of the National Immunization Program for cervical cancer vaccination, was finally miscarried, the Korea Centers for Diseases Control...
Every category for 2017 insurance cost negotiation is settled with pharmacy for maximum
In the result of the 2017’s insurance cost negotiation, the Korean Pharmaceutical Association(KPA) received the highest rise rate(excluding maternity) per category at 3.5%. The pharmacy equivalent index exceeded KRW 8...
Antismoking treatment ‘Champix’ recording KRW 12.6 billion only in 1st quarter
The Pfizer Pharmaceuticals Korea’s antismoking treatment, ‘Champix(varenicline),’ has shown a fierce growth together with the government’s antismoking treatment support project.
According to the IMS data of the 1st ...
What are chances for domestic biosimilars to succeed in global market?
Foreign expansion of Korean competitive biomedicines is going to be active.
The leading biosimilar companies are Celltrion and Samsung Bioepis. The two companies gave notices of the launch of the autoimmune treatment...
SK Chemicals’ domestic hemophilia treatment enters U.S. market
On the 27th, SK Chemicals(CEO Man-hoon Park) announced the final commercialization approval of ‘NBP601,’ a hemophilia treatment, from the U.S. Food and Drug Administration(FDA).
NBP601 is the first drug which acquir...
Miscarriages of auction on Gardasil and Cervarix, delaying NIP enforcement
Attracting interests through the adoption of the National Immunization Program on June, the cervical cancer vaccination for children at the age of 12 is expected to be delayed.
According to the industry concerned on...
Asthma drug, Xolair, introduced as prefilled syringe
The asthma treatment which has not been able to pass the wall of the health insurance since its approval in 2007, Xolair(generic name: omalizumab), was introduced as a prefilled syringe type.
According to the Ministr...
Japan’s ‘anticancer-CNS’ vs Korea’s ‘anticancer-antidiabetic’
The current environment of the Korean pharmaceutical industry is evaluated as similar to the Japanese 1990s in many aspects, such as the amount of sales, the R&D development steps and the government’s drug pricing pol...
